Compounds > c.i. 42510
Page last updated: 2024-08-21

c.i. 42510 and Day Blindness

c.i. 42510 has been researched along with Day Blindness in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Feucht, N; Lohmann, CP; Maier, MM; Mueller, C; Rass, S1
Kodjikian, L; Savary, P1

Other Studies

2 other study(ies) available for c.i. 42510 and Day Blindness

ArticleYear
[Transconjunctival sutureless pars plana vitrectomy and Brilliant Peel (BP)-assisted ILM peeling in patients with macular holes].
    Klinische Monatsblatter fur Augenheilkunde, 2013, Volume: 230, Issue:7

    Topics: Aged; Aged, 80 and over; Combined Modality Therapy; Conjunctiva; Epiretinal Membrane; Female; Humans; Male; Middle Aged; Retinal Perforations; Retrospective Studies; Rosaniline Dyes; Sutures; Treatment Outcome; Vision Disorders; Vitrectomy

2013
Intraretinal brilliant blue G infiltration during internal limiting membrane peeling.
    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2014, Volume: 252, Issue:6

    Topics: Aged; Basement Membrane; Chromogenic Compounds; Epiretinal Membrane; Eye Injuries, Penetrating; Female; Humans; Retina; Retinal Perforations; Rosaniline Dyes; Tomography, Optical Coherence; Vision Disorders; Visual Acuity; Visual Field Tests; Visual Fields; Vitrectomy

2014